HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, H. Articles by Robertson, R. P. Search for Related Content PubMed PubMed Citation Articles by Zhou, H. Articles by Robertson, R. P. Social Bookmarking                What's this?

Regulation of -Cell Function by the ß-Cell During Hypoglycemia in Wistar Rats: the "Switch-off" Hypothesis

¹ Pacific Northwest Research Institute, University of Washington, Seattle, Washington
² Department of Medicine, University of Washington, Seattle, Washington
³ Department of Pharmacology, University of Washington, Seattle, Washington

The glucagon response is the first line of defense against hypoglycemia and is lost in insulin-dependent diabetes. The ß-cell "switch-off" hypothesis proposes that a sudden cessation of insulin secretion from ß-cells into the portal circulation of the islet during hypoglycemia is a necessary signal for the glucagon response from downstream -cells. Although indirect evidence exists to support this hypothesis, it has not been directly tested in vivo by provision and then discontinuation of regional reinsulinization of -cells at the time of a hypoglycemic challenge. We studied streptozotocin (STZ)-induced diabetic Wistar rats that had no glucagon response to a hypoglycemic challenge. We reestablished insulin regulation of the -cell by regionally infusing insulin (0.025 µU/min) directly into the superior pancreaticoduodenal artery (SPDa) of STZ-administered rats at an infusion rate that did not alter systemic venous glucose levels. SPDa insulin infusion was switched off simultaneously when blood glucose fell to <60 mg/dl after a jugular venous insulin injection. This maneuver restored the glucagon response to hypoglycemia (peak change within 5–10 min = 326 ± 98 pg/ml, P < 0.05; and peak change within 15–20 min = 564 ± 148 pg/ml, P < 0.01). No response was observed when the SPDa insulin infusion was not turned off (peak change within 5–10 min = 44 ± 85 pg/ml, P = NS; and peak change within 15–20 min = 67 ± 97 pg/ml, P = NS) or when saline instead of insulin was infused and then switched off (peak change within 5–10 min = –44 ± 108 pg/ml, P = NS; and peak change within 15–20 min = –13 ± 43 pg/ml, P = NS). No responses were observed during euglycemia (peak change within 5–10 min = 48 ± 35 pg/ml, P = NS; and peak change within 15–20 min = 259 ± 129 pg/ml, P = NS) or hyperglycemia (peak change within 5–10 min = 49 ± 62 pg/ml, P = NS; and peak change within 15–20 min = 138 ± 87 pg/ml, P = NS). Thus, the glucagon response to hypoglycemia that was absent in rats made diabetic by STZ was restored by regional infusion and then discontinuation of insulin. These data provide direct in vivo support for the ß-cell "switch-off" hypothesis and indicate that the -cell is not intrinsically abnormal in insulin-dependent diabetes because of STZ-induced destruction of ß-cells.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Zhou, T. Zhang, M. Bogdani, E. Oseid, S. Parazzoli, M.-C. Vantyghem, J. Harmon, M. Slucca, and R. P. Robertson Intrahepatic Glucose Flux as a Mechanism for Defective Intrahepatic Islet {alpha}-Cell Response to Hypoglycemia Diabetes, June 1, 2008; 57(6): 1567 - 1574. [Abstract] [Full Text] [PDF]

				H. Zhou, T. Zhang, E. Oseid, J. Harmon, N. Tonooka, and R. P. Robertson Reversal of Defective Glucagon Responses to Hypoglycemia in Insulin-Dependent Autoimmune Diabetic BB Rats Endocrinology, June 1, 2007; 148(6): 2863 - 2869. [Abstract] [Full Text] [PDF]

				H. Zhou, T. Zhang, J. S. Harmon, J. Bryan, and R. P. Robertson Zinc, Not Insulin, Regulates the Rat {alpha}-Cell Response to Hypoglycemia In Vivo Diabetes, April 1, 2007; 56(4): 1107 - 1112. [Abstract] [Full Text] [PDF]

				J. Gromada, I. Franklin, and C. B. Wollheim {alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains Endocr. Rev., February 1, 2007; 28(1): 84 - 116. [Abstract] [Full Text] [PDF]

				Y. M. Leung, I. Ahmed, L. Sheu, X. Gao, M. Hara, R. G. Tsushima, N. E. Diamant, and H. Y. Gaisano Insulin Regulates Islet {alpha}-Cell Function by Reducing KATP Channel Sensitivity to Adenosine 5'-Triphosphate Inhibition Endocrinology, May 1, 2006; 147(5): 2155 - 2162. [Abstract] [Full Text] [PDF]

				J. J. Meier, L. L. Kjems, J. D. Veldhuis, P. Lefebvre, and P. C. Butler Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. Diabetes, April 1, 2006; 55(4): 1051 - 1056. [Abstract] [Full Text] [PDF]

				K. E. Inouye, J. T. Y. Yue, O. Chan, T. Kim, E. M. Akirav, E. Park, M. C. Riddell, E. Burdett, S. G. Matthews, and M. Vranic Effects of Insulin Treatment without and with Recurrent Hypoglycemia on Hypoglycemic Counterregulation and Adrenal Catecholamine-Synthesizing Enzymes in Diabetic Rats Endocrinology, April 1, 2006; 147(4): 1860 - 1870. [Abstract] [Full Text] [PDF]

				P. E. Cryer Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes Diabetes, December 1, 2005; 54(12): 3592 - 3601. [Abstract] [Full Text] [PDF]

				A. Munoz, M. Hu, K. Hussain, J. Bryan, L. Aguilar-Bryan, and A. S. Rajan Regulation of Glucagon Secretion at Low Glucose Concentrations: Evidence for Adenosine Triphosphate-Sensitive Potassium Channel Involvement Endocrinology, December 1, 2005; 146(12): 5514 - 5521. [Abstract] [Full Text] [PDF]

				Z. Israelian, N. R. Gosmanov, E. Szoke, M. Schorr, S. Bokhari, P. E. Cryer, J. E. Gerich, and C. Meyer Increasing the Decrement in Insulin Secretion Improves Glucagon Responses to Hypoglycemia in Advanced Type 2 Diabetes Diabetes Care, November 1, 2005; 28(11): 2691 - 2696. [Abstract] [Full Text] [PDF]

				M. R. Rickels, M. H. Schutta, R. Mueller, J. F. Markmann, C. F. Barker, A. Naji, and K. L. Teff Islet Cell Hormonal Responses to Hypoglycemia After Human Islet Transplantation for Type 1 Diabetes Diabetes, November 1, 2005; 54(11): 3205 - 3211. [Abstract] [Full Text] [PDF]

				C. Shiota, J. V. Rocheleau, M. Shiota, D. W. Piston, and M. A. Magnuson Impaired glucagon secretory responses in mice lacking the type 1 sulfonylurea receptor Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E570 - E577. [Abstract] [Full Text] [PDF]

				J. Diao, Z. Asghar, C. B. Chan, and M. B. Wheeler Glucose-regulated Glucagon Secretion Requires Insulin Receptor Expression in Pancreatic {alpha}-Cells J. Biol. Chem., September 30, 2005; 280(39): 33487 - 33496. [Abstract] [Full Text] [PDF]

				M. A. Ravier and G. A. Rutter Glucose or Insulin, but not Zinc Ions, Inhibit Glucagon Secretion From Mouse Pancreatic {alpha}-Cells Diabetes, June 1, 2005; 54(6): 1789 - 1797. [Abstract] [Full Text] [PDF]

				N. R. Gosmanov, E. Szoke, Z. Israelian, T. Smith, P. E. Cryer, J. E. Gerich, and C. Meyer Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans Diabetes Care, May 1, 2005; 28(5): 1124 - 1131. [Abstract] [Full Text] [PDF]

				B. Raju and P. E. Cryer Loss of the Decrement in Intraislet Insulin Plausibly Explains Loss of the Glucagon Response to Hypoglycemia in Insulin-Deficient Diabetes: Documentation of the Intraislet Insulin Hypothesis in Humans Diabetes, March 1, 2005; 54(3): 757 - 764. [Abstract] [Full Text] [PDF]

				K. M. Hope, P. O. T. Tran, H. Zhou, E. Oseid, E. Leroy, and R. P. Robertson Regulation of {alpha}-Cell Function by the {beta}-Cell in Isolated Human and Rat Islets Deprived of Glucose: the "Switch-off" Hypothesis Diabetes, June 1, 2004; 53(6): 1488 - 1495. [Abstract] [Full Text] [PDF]